World’s Top 20 Companies in Bilirubin Colorimeter Assay Market 2024: Statistics Report till 2035

Description

According to a research report published by Spherical Insights & Consulting, The Global Bilirubin Colorimeter Assay Market Size is projected to Grow from USD 147.3 Million in 2024 to USD 374.8 Million by 2035, at a CAGR of 8.86% during the forecast period 2024–2035. It is driven by the rise in neonatal jaundice cases, the growing prevalence of liver disease, and the need for quick, point-of-care diagnostics. This market is growing due to improved healthcare infrastructure in developing countries and a greater use of automated diagnostic systems, as it is esteemed for its precision in measuring serum bilirubin through spectrophotometry.

 

 

Introduction

The bilirubin colorimeter assay market refers to the industry involved in the research, development, manufacturing, and supply of diagnostic products and systems used to measure bilirubin levels in blood or serum samples through colorimetric methods. In this market, key components such as bilirubin assay kits, reagents, calibrators, analyzers, and laboratory instruments are widely used in hospitals, diagnostic laboratories, neonatal care units, and research institutions to detect jaundice and monitor liver function. Commonly used bilirubin testing methods include direct and total bilirubin assays based on diazo reactions and photometric/colorimetric measurement principles, which are valued for their accuracy, speed, and cost-effectiveness in clinical settings. There is a growing demand for bilirubin colorimeter assays driven by the increasing incidence of neonatal hyperbilirubinemia, rising burden of liver diseases, and expanding routine diagnostic screening programs. Additionally, the growing focus on early disease detection, improvements in laboratory automation, and the expansion of healthcare infrastructure are encouraging wider adoption of bilirubin diagnostic solutions. Increased regulatory oversight and quality standards are also prompting manufacturers to develop reliable, standardized, and user-friendly assay products. The future of the bilirubin colorimeter assay market is expected to witness stronger integration of automated diagnostics, point-of-care testing technologies, and improved reagent stability, enabling more efficient and accurate bilirubin analysis across healthcare settings.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bilirubin Colorimeter Assay Market.

 

Bilirubin Colorimeter Assay Market Size & Statistics

• The Market Size for Bilirubin Colorimeter Assay Was Estimated to be worth USD 147.3 Million in 2024.
• The Market Size is Going to Expand at a CAGR of 8.86% between 2024 and 2035.
• The Global Bilirubin Colorimeter Assay Market Size is anticipated to reach USD 374.8 Million by 2035.
• Asia Pacific is estimated to generate the highest demand during the forecast period in The Bilirubin Colorimeter Assay Market.
• North America is projected to grow the fastest during the forecast period in The Bilirubin Colorimeter Assay Market

 

 

Regional growth and demand

 

North America is expected to grow the fastest during the forecast period in the bilirubin colorimeter assay market. The strong presence of advanced diagnostic laboratories, increasing neonatal screening programs, and rising incidence of liver-related disorders are driving demand for bilirubin testing solutions across the region. The United States leads the regional market due to its developed healthcare infrastructure, high awareness regarding early disease diagnosis, and broad adoption of automated clinical chemistry analyzers. In addition, growing investments in hospital diagnostics, favorable reimbursement environments, and the presence of major in vitro diagnostics companies are further supporting market expansion. Strict regulatory and quality standards are also encouraging the use of high-precision assay kits and instruments.

 

Asia Pacific is anticipated to generate the highest demand during the forecast period in the bilirubin colorimeter assay market. The region’s market growth is driven by rising birth rates, increasing incidence of neonatal jaundice, expanding healthcare access, and growing investments in diagnostic laboratory infrastructure across countries such as China, India, Japan, and South Korea. Increasing awareness regarding timely bilirubin testing in newborns and liver disease patients is contributing to greater product adoption. Rapid development of hospital networks, rising demand for affordable diagnostic solutions, and increasing government efforts to improve maternal and infant healthcare are also accelerating demand for bilirubin colorimeter assay products in the region.

 

 

Top 10 trends in the Bilirubin Colorimeter Assay Market

1. Rise of Non-Invasive Transcutaneous Bilirubinometry (TcB)
2. Expansion of Point-of-Care (POC) Testing
3. Surging Demand for Neonatal Screening
4. Growth in Liver Function Testing (LFT) Market
5. Adoption of Advanced Digital Spectrophotometry
6. Increase in Laboratory-Based Testing Volume
7. Growing Focus on Pediatric and Adult Diagnostics
8. Technological Innovation in Consumables
9. Expansion in Developing Economies
10. Integration of Data Management and Connectivity

 

1. Rise of Non-Invasive Transcutaneous Bilirubinometry (TcB)

In order to reduce pain and risk in neonates, there is a significant movement away from conventional blood drawing methods toward the use of transcutaneous devices that provide quick bilirubin evaluations in newborns.

 

2. Expansion of Point-of-Care (POC) Testing

Hospitals and clinics are progressively utilizing portable colorimeter assays, which provide instant bilirubin results in NICUs and at the bedside, thus reducing turnaround time and enhancing patient management.

 

3. Surging Demand for Neonatal Screening

The growing occurrence of neonatal jaundice (hyperbilirubinemia) globally is a major factor necessitating dependable, rapid, and user-friendly bilirubin screening tools for newborn care.

 

4. Growth in Liver Function Testing (LFT) Market

The increasing prevalence of liver-related diseases such as hepatitis and cirrhosis is driving the demand for serum bilirubin measurement, resulting in LFTs becoming the largest segment of applications.

 

5. Adoption of Advanced Digital Spectrophotometry

Modern colorimeters are progressively adopting advanced multi-wavelength spectrophotometry, which improves precision and minimizes interference from other serum components.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the temporary power market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bilirubin Colorimeter Assay Market.

 

Top 20 Companies Leading the Bilirubin Colorimeter Assay Market

1. Hoffmann-La Roche Ltd.
2. Siemens Healthineers AG
3. Abbott Laboratories
4. Beckman Coulter Inc.
5. Randox Laboratories Ltd.
6. SEKISUI Diagnostics
7. Fortress Diagnostics
8. Agappe Diagnostics Ltd.
9. Nova Biomedical
10. Radiometer Medical ApS
11. Drägerwerk AG & Co. KGaA
12. Advanced Instruments LLC
13. Natus Medical Incorporated
14. Konica Minolta Inc.
15. Micro Lab Instruments
16. Cell Biolabs Inc.
17. Sigma-Aldrich
18. Tulip Diagnostics
19. BioVision Inc
20. Express Biotech International

 

1. Hoffmann-La Roche Ltd.

Headquarters: Basel, Switzerland

Hoffmann-La Roche Ltd. is a Swiss multinational healthcare company founded in 1896. The company specializes in pharmaceuticals and diagnostics, with a strong presence in clinical chemistry, immunodiagnostics, molecular diagnostics, and laboratory automation. Roche provides a broad range of diagnostic systems and reagents used in hospitals and laboratories worldwide, including solutions relevant to bilirubin testing and liver function assessment. The company operates globally with a wide commercial footprint and significant investments in research, innovation, and digital healthcare technologies.

 

2. Siemens Healthineers AG

Headquarters: Erlangen, Germany

Siemens Healthineers AG is a German multinational medical technology company with origins dating back to 1847 and established as a dedicated healthcare business under the Siemens brand. The company specializes in diagnostic imaging, laboratory diagnostics, advanced therapies, and digital health solutions. Siemens Healthineers offers clinical laboratory systems and chemistry analyzers that support bilirubin assay testing and broader liver function analysis in hospitals and diagnostic laboratories. The company serves healthcare providers worldwide and continues to invest in automation, artificial intelligence, and workflow optimization technologies.

 

3. Abbott Laboratories

Headquarters: Abbott Park, Illinois, United States

Abbott Laboratories is an American multinational healthcare and medical devices company founded in 1888. The company specializes in diagnostics, medical devices, nutrition, and branded generic medicines. Abbott offers a comprehensive portfolio of clinical chemistry systems, diagnostic reagents, and laboratory solutions that are widely used in routine bilirubin analysis and liver function testing. The company operates globally and has made significant investments in innovation, laboratory automation, and accessible diagnostic technologies to strengthen its presence in the in vitro diagnostics market.

 

4. Beckman Coulter Inc.

Headquarters: Brea, California, United States

Beckman Coulter Inc. is an American clinical diagnostics and life sciences company founded in 1935. The company specializes in clinical chemistry, hematology, immunoassay, microbiology, and laboratory automation solutions. Beckman Coulter provides a wide range of analyzers, reagents, and diagnostic systems used in hospitals and laboratories, including platforms relevant to bilirubin colorimetric testing and liver function diagnostics. The company operates internationally and continues to focus on improving laboratory efficiency, diagnostic accuracy, and workflow integration through innovation and advanced technology.

 

5. Randox Laboratories Ltd.

Headquarters: Crumlin, County Antrim, Northern Ireland, United Kingdom

Randox Laboratories Ltd. is a British diagnostics company founded in 1982. The company specializes in the development and manufacture of diagnostic reagents, quality control materials, and laboratory instruments for clinical testing applications. Randox provides clinical chemistry solutions and assay products used in laboratories for routine biochemical analysis, including bilirubin measurement and liver function assessment. The company serves customers worldwide and continues to invest in diagnostic innovation, product development, and laboratory quality assurance technologies.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bilirubin Colorimeter Assay Market.

 

Company Profiles

 

1. Hoffmann-La Roche Ltd.

 

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

 

2. Siemens Healthineers AG
3. Abbott Laboratories
4. Beckman Coulter Inc.
5. Randox Laboratories Ltd.
6. SEKISUI Diagnostics
7. Fortress Diagnostics
8. Agappe Diagnostics Ltd.
9. Nova Biomedical
10. Radiometer Medical ApS
11. Drägerwerk AG & Co. KGaA
12. Advanced Instruments LLC
13. Natus Medical Incorporated
14. Konica Minolta Inc.
15. Micro Lab Instruments
16. Cell Biolabs Inc.
17. Sigma-Aldrich
18. Tulip Diagnostics
19. BioVision Inc
20. Express Biotech International

 

Our Reports

https://www.sphericalinsights.com/reports/japan-silver-tourism-market 
https://www.sphericalinsights.com/reports/japan-wildlife-tourism-market 
https://www.sphericalinsights.com/reports/mexico-automotive-aftermarket-market 
https://www.sphericalinsights.com/reports/europe-anti-aging-supplements-market 
 

Conclusion

 

In conclusion, the global bilirubin colorimeter assay market is entering a significant growth phase, driven by the increasing importance of neonatal jaundice screening, liver disease diagnostics, and improved access to clinical testing services. Asia Pacific is emerging as the largest demand hub, while North America continues to accelerate growth through advanced diagnostic infrastructure and high clinical testing adoption. As hospitals, neonatal care units, and diagnostic laboratories increasingly rely on fast, accurate, and cost-effective bilirubin measurement solutions, companies investing in assay standardization, automation, and digital diagnostic workflows are likely to shape the competitive landscape in the decade ahead.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bilirubin Colorimeter Assay Market.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter